Afuco™ Anti-Human NONO ADCC Therapeutic Antibody (PAT-LM1), ADCC Enhanced
Anti-NONO ADCC Enhanced Antibody (PAT-LM1) is an ADCC enhanced antibody produced by our Afuco™ platform. PAT-LM1 bingding to non-POU domain-containing octamer-binding protein (NONO) is a natural human antibody that can be used as a potential treatment for multiple types of cancer, with a particularly strong potency against colon, lung, breast, ovary, pancreatic cancers, lympoma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-660CL |
| Pricing | Inquiry |
| Host | Human |
| Target | NONO |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | WB, ELISA, FC, MTT assay |
| Storage | Store at -20°C. Open under aseptic conditions. |